본문 바로가기

ICH

ICH Q10 3.2.1

3. CONTINUAL IMPROVEMENT OF PROCESS PERFORMANCE AND PRODUCT QUALITY

조항 원문

Process Performance and Product Quality Monitoring System Pharmaceutical companies should plan and execute a system for the monitoring of process performance and product quality to ensure a state of control is maintained. An effective monitoring system provides assurance of the continued capability of processes and controls to produce a product of desired quality and to identify areas for continual improvement. The process performance and product quality monitoring system should:

(a) Use quality risk management to establish the control strategy. This can include parameters and attributes related to drug substance and drug product materials and components, facility and equipment operating conditions, in- process controls, finished product specifications, and the associated methods and frequency of monitoring and control. The control strategy should facilitate timely feedback / feedforward and appropriate corrective action and preventive action;

(b) Provide the tools for measurement and analysis of parameters and attributes identified in the control strategy (e.g., data management and statistical tools);

(c) Analyse parameters and attributes identified in the control strategy to verify continued operation within a state of control;

(d) Identify sources of variation affecting process performance and product quality for potential continual improvement activities to reduce or control variation;

(e) Include feedback on product quality from both internal and external sources, e.g., complaints, product rejections, non-conformances, recalls, deviations, audits and regulatory inspections and findings;

(f) Provide knowledge to enhance process understanding, enrich the design space (where established), and enable innovative approaches to process validation.

Table I: Application of Process Performance and Product Quality Monitoring System throughout the Product Lifecycle

Pharmaceutical Technology Commercial Product Development Transfer Manufacturing Discontinuation

Process and product Monitoring during A well-defined system Once manufacturing knowledge generated scale-up activities can for process ceases, monitoring and process and provide a preliminary performance and such as stability product monitoring indication of process product quality testing should conducted throughout performance and the monitoring should be continue to development can be successful integration applied to assure completion of the used to establish a into manufacturing. performance within a studies. Appropriate control strategy for Knowledge obtained state of control and to action on marketed manufacturing. during transfer and identify improvement product should scale up activities can areas. continue to be be useful in further executed according to developing the control regional regulations. strategy.

본문은 원문(영어)입니다. 국문 번역은 준비 중입니다.

출처: International Council for Harmonisation (ICH) · © ICH. Per the legal notice in each guideline, the document may be used, reproduced and distributed provided ICH's copyright is acknowledged; any adaptation or translation must be labelled as such and must not imply ICH endorsement. · 수집일 2026-11-15

Weekly Newsletter

이런 지적, 매주 월요일 한국어로 받아보세요

FDA·EMA·식약처의 새 지적과 조치를 공식 원문 링크와 함께 보내드립니다. 사이트에 새로운 기능이 생기면 함께 안내드립니다. 구독은 언제든 한 번의 클릭으로 해지할 수 있습니다.

이번 주 소식 먼저 보기

매주 월요일 발송 · 구독 신청 시 확인 메일이 발송됩니다 · 수신거부는 모든 메일 하단에서 가능합니다.